Veradigm (NASDAQ:MDRX – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “hold” rating in a research report issued to clients and investors on Saturday.
Veradigm Trading Down 3.2%
Veradigm stock opened at $4.26 on Friday. The stock has a 50-day moving average price of $4.62 and a 200 day moving average price of $4.72. Veradigm has a 52 week low of $3.00 and a 52 week high of $6.00. The stock has a market cap of $463.91 million, a PE ratio of 23.25 and a beta of 0.54.
Veradigm Company Profile
Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.
Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.
Featured Articles
- Five stocks we like better than Veradigm
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
